Researchers say the results are encouraging but also shared cautions. More than half of children in early stages of an ongoing study were able to eat a food they were allergic to one year after ...

Alvotech (NASDAQ:ALVO) reported positive findings from a pharmacokinetic trial evaluating AVT80, its experimental biosimilar to Entyvio, after the study successfully achieved all primary objectives.

Stallergenes Greer, a global leader in allergy therapeutics, announced today that its Phase IIIb clinical study (YOBI, YOung patients and BIrch allergy), designed to confirm the safety and efficacy of ...

Immix Biopharma reported successful dosing of six patients in its Phase 1b trial for the CAR-T therapy NXC-201. The press release acknowledges that no drugs are currently FDA approved for patients ...

THE WOODLANDS, Texas, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced the completion of patient enrollment in the PROGRESS (A Phase 2b, Dose-ranging, ...

A study has developed a reliable way to measure whether seriously ill hospitalized patients receive medical care that aligns with their personal goals. The research, involving 109 seriously ill ...

n = number of patients included in each study group for safety and tolerability assessments Abbreviations: EOS: End of Study (week 16); BID: twice daily; CBD: cannabidiol; QD: once daily. Of the DHT ...

Want to have successful IVF? If you're an older woman, find some donor eggs. Most successful fertility treatments for women 43 and older rely on donor eggs, researchers report in the journal ...

Gage R&R is all about the integrity of your measurement system and its ability to capture the true values of what you are ...

Stallergenes Greer, a global leader in allergy therapeutics, announced today that its Phase IIIb clinical study (YOBI, YOung patients and BIrch allergy), designed to confirm the safety and efficacy of ...